Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Assessing cardiac biomarkers results in a moderate improvement in the ability to predict microvascular complications in patients with Type 2 diabetes, say researchers.
Study author Naveed Sattar (University of Glasgow, UK) and colleagues note that prediction of microvascular events is not currently recommended in guidelines, but say that this “is largely due to a lack of evidence at present regarding evidence-based therapies to prevent onset of microvascular events.”
They say: “Our results are thus important, since prediction of microvascular events, in particular nephropathy, would be useful for future trials of new agents designed to prevent or slow progression of nephropathy, an area of intense interest and activity.”
http://www.medwirenews.com/57/10563...crovascular_risk_prediction_in_diabetics.html
Study author Naveed Sattar (University of Glasgow, UK) and colleagues note that prediction of microvascular events is not currently recommended in guidelines, but say that this “is largely due to a lack of evidence at present regarding evidence-based therapies to prevent onset of microvascular events.”
They say: “Our results are thus important, since prediction of microvascular events, in particular nephropathy, would be useful for future trials of new agents designed to prevent or slow progression of nephropathy, an area of intense interest and activity.”
http://www.medwirenews.com/57/10563...crovascular_risk_prediction_in_diabetics.html